We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$36.5B
AUM Growth
+$3.93B
(+12%)
Cap. Flow
+$651M
Cap. Flow
% of AUM
1.78%
Top 10 Holdings %
Top 10 Hldgs %
7.68%
Holding
3,587
New
780
Increased
747
Reduced
671
Closed
866
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$223M |
| 2 |
TJX Companies
TJX
|
+$191M |
| 3 |
TransDigm Group
TDG
|
+$157M |
| 4 |
Ingersoll Rand
IR
|
+$155M |
| 5 |
BP
BP
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 2 |
Eaton
ETN
|
+$261M |
| 3 |
Union Pacific
UNP
|
+$252M |
| 4 |
Analog Devices
ADI
|
+$240M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.39% |
| 2 | Financials | 11.28% |
| 3 | Technology | 9.98% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Healthcare | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Houlihan Lokey
HLI
$9.04B
| $45.8K | ﹤0.01% |
525
-42,622
| -99% | -$3.83M |
|
|
TSE
2327
DELISTED
Trinseo
TSE
| $45.4K | ﹤0.01% |
2,000
-46,882
| -96% | -$1.03M |
|
2328
Ambev
ABEV
$42.7B
| $45.4K | ﹤0.01% |
16,678
-238,091
| -93% | -$694K |
|
|
EQRX
2329
DELISTED
EQRx, Inc. Common Stock
EQRX
| $45.3K | ﹤0.01% |
+18,406
| New | +$72.5K |
|
2330
Terreno Realty
TRNO
$7.48B
| $44.7K | ﹤0.01% |
+786
| New | +$44.1K |
|
2331
Jones Lang LaSalle
JLL
$16.9B
| $44.6K | ﹤0.01% |
+280
| New | +$44.6K |
|
|
JGGCW
2332
DELISTED
Jaguar Global Growth Corporation I Warrant
JGGCW
| $43.6K | ﹤0.01% |
150,000
| – | – |
|
2333
The Greenbrier Companies
GBX
$1.42B
| $43.6K | ﹤0.01% |
1,299
-31,046
| -96% | -$1.03M |
|
2334
Seres Therapeutics
MCRB
$45.6M
| $43.3K | ﹤0.01% |
387
-377
| -49% | -$50.5K |
|
2335
Delek US
DK
$4.07B
| $43.3K | ﹤0.01% |
+1,603
| New | +$47.3K |
|
2336
Upwork
UPWK
$1.07B
| $42.7K | ﹤0.01% |
4,093
-263,255
| -98% | -$3.25M |
|
2337
Medifast
MED
$130M
| $42.6K | ﹤0.01% |
369
-104,249
| -100% | -$12.1M |
|
2338
Karyopharm Therapeutics
KPTI
$45.3M
| $41.6K | ﹤0.01% |
817
-38,887
| -98% | -$2.7M |
|
2339
Insulet
PODD
$10.1B
| $41.5K | ﹤0.01% |
141
-138,985
| -100% | -$38.3M |
|
|
BPMC
2340
DELISTED
Blueprint Medicines
BPMC
| $41.2K | ﹤0.01% |
+941
| New | +$45.1K |
|
2341
Enviri
NVRI
$579M
| $41.2K | ﹤0.01% |
+6,550
| New | +$39K |
|
2342
Acadia Pharmaceuticals
ACAD
$4.86B
| $41K | ﹤0.01% |
+2,578
| New | +$40.3K |
|
|
DM
2343
DELISTED
Desktop Metal, Inc.
DM
| $40.9K | ﹤0.01% |
3,007
-8,118
| -73% | -$169K |
|
2344
Kiniksa Pharmaceuticals
KNSA
$5.96B
| $40.4K | ﹤0.01% |
+2,695
| New | +$39.2K |
|
2345
Mattel
MAT
$4.29B
| $40.4K | ﹤0.01% |
2,262
-2,884,828
| -100% | -$52.3M |
|
2346
Clean Harbors
CLH
$17B
| $40.3K | ﹤0.01% |
353
-16,862
| -98% | -$1.97M |
|
2347
SoundHound AI Warrant
SOUNW
$662M
| $39.6K | ﹤0.01% |
264,234
| – | – |
|
|
SCRMW
2348
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
| $39.3K | ﹤0.01% |
166,666
| – | – |
|
2349
Spectrum Brands
SPB
$2.06B
| $39.2K | ﹤0.01% |
643
-27,428
| -98% | -$1.38M |
|
2350
Aveanna Healthcare
AVAH
$2.65B
| $39K | ﹤0.01% |
49,957
+17,776
| +55% | +$18.6K |
|
Similar funds
BC
Balyasny Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Balyasny Asset Management held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Balyasny Asset Management's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.
By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
- Balyasny Asset Management's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
- Balyasny Asset Management added most to Visa in Q4 2022, an estimated $223M increase.
- Balyasny Asset Management's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
- Balyasny Asset Management fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
- Balyasny Asset Management's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
- Balyasny Asset Management opened 780 new positions and closed 866 in Q4 2022.
- Balyasny Asset Management's portfolio value rose 12% quarter-over-quarter to $36.5B.
Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.